thiophenes has been researched along with siponimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dev, KK; Mir, AK; O'Sullivan, C; Schubart, A | 1 |
| Busra Azizoglu, Z; Canatan, H; Eken, A; Zehra Okus, F | 1 |
2 other study(ies) available for thiophenes and siponimod
| Article | Year |
|---|---|
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Astrocytes; Azetidines; Benzyl Compounds; beta-Alanine; Calcium Signaling; Cerebellum; Demyelinating Diseases; eIF-2 Kinase; Humans; Immunosuppressive Agents; In Vitro Techniques; Indans; Interleukin-6; Lysophosphatidylcholines; Mice; Myelin Basic Protein; Organ Culture Techniques; Oxadiazoles; Protein Transport; Receptors, Lysosphingolipid; Thiophenes; Time Factors | 2016 |
S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo.
Topics: Animals; Azetidines; Benzyl Compounds; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interleukin-23; Lysophospholipids; Mice; Neurodegenerative Diseases; Oxadiazoles; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; T-Lymphocytes, Regulatory; Th17 Cells; Thiophenes | 2022 |